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Despite its good resolution, magnetic resonance imaging intrinsically has low sensitivity. Recently, contrast agent
nanoparticles have been used as sensitivity and contrast enhancer. The aim of this study was to investigate a new
controlled synthesis method for gadolinium oxide-based nanoparticle preparation. For this purpose,
diethyleneglycol coating of gadolinium oxide (Gd2O3-DEG) was performed using new supervised polyol route, and
small particulate gadolinium oxide (SPGO) PEGylation was obtained with methoxy-polyethylene-glycol-silane
(550 and 2,000 Da) coatings as SPGO-mPEG-silane550 and 2,000, respectively. Physicochemical characterization and
magnetic properties of these three contrast agents in comparison with conventional Gd-DTPA were verified by
dynamic light scattering transmission electron microscopy, Fourier transform infrared spectroscopy, inductively
coupled plasma, X-ray diffraction, vibrating sample magnetometer, and the signal intensity and relaxivity
measurements were performed using 1.5-T MRI scanner.
As a result, the nanoparticle sizes of Gd2O3-DEG, SPGO-mPEG-silane550, and SPGO-mPEG-silane2000 could be
reached to 5.9, 51.3, 194.2 nm, respectively. The image signal intensity and longitudinal (r1) and transverse relaxivity
(r2) measurements in different concentrations (0.3 to approximately 2.5 mM), revealed the r2/r1 ratios of 1.13, 0.89,
33.34, and 33.72 for Gd-DTPA, Gd2O3-DEG, SPGO-mPEG-silane550, and SPGO-mPEG-silane2000, respectively.
The achievement of new synthesis route of Gd2O3-DEG resulted in lower r2/r1 ratio for Gd2O3-DEG than Gd-DTPA
and other previous synthesized methods by this and other groups. The smaller r2/r1 ratios of two PEGylated-SPGO
contrast agents in our study in comparison with r2/r1 ratio of previous PEGylation (r2/r1 = 81.9 for mPEG-silane 6,000
MW) showed that these new three introduced contrast agents could potentially be proper contrast enhancers for
cellular and molecular MR imaging.
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Magnetic resonance imaging (MRI) is one of the various
techniques used widely as imaging tools in clinical diag-
nosis. Unlike other two methods of computed tomog-
raphy (CT) and positron emission tomography (PET),
MRI has no ionizing radiation, while, with same spatial
resolution (SR) as CT, also having a high SR of 0.2 to 0.3
mm compared to 3 mm of PET scan [1,2]. However, the
sensitivity and intrinsic contrast of the MRI are low. Im-
aging contrast depends on signal intensity difference be-
tween two adjacent tissues or areas. The effective factors
in the signal intensity are proton spin density (N), spin–
lattice or longitudinal relaxation time (T1), and spin-spin
relaxation or transverse relaxation time (T2) as shown in
Equation 1:
SI∝N :ð1 eTR=T1 Þ:eTE=T2 ð1Þ
where TR is the repetition time and TE is the echo time
of MRI pulse sequence which determine the contrast be-
tween tissues [3].
Contrast agents can modify the signal intensity in dif-
ferent tissues and enhance intrinsic contrast. These are
categorized according to the signal intensity produced
on T1- and T2-weighted images: ‘positive’ (high signal in-
tensity) or ‘negative’ (low signal intensity) [4,5].
Gd3+ ions are generally used as a positive contrast
agent which has seven unpaired electrons and produce a
magnetic moment that is significantly stronger than a
proton (nearly 700 times), and its physical properties are
suitable for reducing the longitudinal (T1) and transverse
(T2) proton relaxation times [6]. The efficiency of the
contrast agent is determined by relaxivity (ri) that
changes the longitudinal and transverse relaxation times.
According to different absorption of agents, this change












i ¼ 1; 2 ð2Þ
where (1/Ti)obs and (1/Ti)d are the relaxation rates (R1
and R2, s
−1) of the sample and aqueous solution, respect-
ively; ri is longitudinal and transverse relaxivity of
the sample (relaxation rates per concentration unit, s−1
mM−1), and [Gd3+] is the gadolinium concentration
(mM) [7].
Despite the good magnetic properties, the free Gd3+
ion is extremely toxic. To reduce its toxicity, it must be
complexed by strong organic chelators, e.g., diethylene
triamine pentaacetic acid (DTPA) which has been used
conventionally in daily MRI examinations [5]. However,
these chelates cause low sensitivity and, thus, requiring a
high tissue concentration of the contrast agent to be ef-
fective for MR imaging.Recently, studies have shown high efficiency and sensi-
tivity of contrast agents when they have been used in
nanoparticles form. The size of the nanoparticles that
can be used in MRI is about 3 to 350 nm that might be
comparable or smaller than a cell (10 to 100 μm), a virus
(20 to 450 nm), a protein (5 to 50 nm), or a gene (2 nm
wide and 10 to 100 nm long) [8,9].
For nanoparticles, various coating materials can reduce
their toxicity and increase their biocompatibility. As a
new surface covering material, this group in a previous
study reported some of the primary magnetic properties
of diethyleneglycol (DEG) in combination with Gd
oxide-based nanoparticles [10]. However, still further
researches on the matters of the synthesis procedure, ef-
fective size, and agglomeration of gadolinium nanoparti-
cles coated with DEG materials are needed to be done
[11-13]. On the other hand, polyethylene glycol (PEG),
due to its considerable physicochemical properties, has
an especial interest as covering of nanoparticle surfaces
[13-17]. Also, it should be noted that PEG has different
molecular weights from 350 to 30,000 (and more) Da
that could be used alone or in conjunction with other
substances such as polylactide-polyethylene glycol and
polylactide-co-glycolide [18-20]. For this reason, these
two groups of surface conjugate materials (DEG and
PEG) could be even useful for covering nanoparticles in
biomedical cellular and molecular imaging applications.
Therefore, here in continuing our previous works, the
assessment of a new supervised DEG synthesis route in
addition to a gadolinium PEGylated (PEG) method in
comparison to the conventionally Gd-DTPA contrast
agent has been determined as the aim of this study. For
this purpose, Gd2O3-DEG was prepared in new synthetic
controlled method, and mPEG-silane grafting at the sur-
face of a new core contrast agent (small particulate
gadolinium oxide, SPGO < 40 nm) was obtained using
two molecular weights of methoxy polyethylene glycol-
silane: 550 and 2,000 Da as SPGO-mPEG-silane550 and
SPGO-mPEG-silane2000. Physicochemical characteriza-
tions and magnetic properties of those three contrast
agents in comparison with conventional Gd-DTPA were
evaluated to find the optimum method and the more ef-
fective contrast agent nanomagnetic for cellular and mo-
lecular magnetic resonance imaging.
Methods
The synthesis of the Gd2O3-DEG nanoparticles
In a new supervised polyol route, for the synthesis of
gadolinium oxide nanocrystals, 2.5 mmol GdCl3-6H2O
dissolved in 12.5 ml DEG was heated to 140°C until a
clear solution was obtained. Then, 3 mmol solid NaOH
was dissolved in 6 ml DEG and then added to the Gd-
containing solution; the temperature of the mixture was
raised to 180°C and held constant for 4 h under reflux
Table 1 DLS size and PdI measurements for the three
nanoparticle contrast agents
Nanoparticle Hydrodynamic diameter(nm) PdI
Gd2O3-DEG 5.9 ± 0.13 0.387
SPGO-mPEG-silane550 51.3 ± 1.46 0.350
SPGO-mPEG-silane2000 194.2 ± 22.1 0.225
The results show a direct relationship between size and molecular weight.
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After cooling, the nanocrystals formed were separated
and purified from agglomerations or large-size particles
by centrifuge filtration for 30 min at 40°C and 2,000 rpm
(filters: polyethersulfone, 0.2 μm, Vivascience Sartorius,
Hannover, Germany). Free Gd3+ ions and excess DEG in
the solution were eliminated by 1,000 MW membrane
(dialysis tubing, benzoylated, Sigma-Aldrich, USA) for
24 h and by 12,000 MW membrane (dialysis tubing cel-
lulose membrane, Sigma-Aldrich, USA) for 24 h across
deionized water, which these sections were not included
in our previous study [13].
The synthesis of the SPGO-mPEG-silane550 and
SPGO-mPEG-silane2000
The process of SPGO-mPEG-silane nanoparticle synthe-
sis was performed using SPGO nanoparticles (<40 nm)
purchased from Sigma-Aldrich (99.999% pure). Briefly, a
solution was prepared by dissolving SPGO (1 g) and 15
mg ml−1 mPEG-silane (mPEG-Silane, MW550, Nanocs,
Inc. (MA, USA) or mPEG-Silane, MW 2000, Laysan Bio,
Inc. (AL, USA)) in deionized water (10 mL); then, the
resulting solution was sonicated at 40°C for 2 h. Large-
size particles were separated by centrifugation (2,000
rpm, 30 min) and the suspension was dialyzed (1,000
and 12,000 MW) as described above [21].
Characterization of the contrast materials
Nanoparticle size measurements were performed three
times repeatedly by dynamic light scattering (DLS, Broo-
khaven Instruments, USA). Also the morphological in-
formation of the nanoparticles was done by transmission
electron microscopy (TEM, CM120 model, Koninklijke
Philips Electronics, Netherlands).
The effects of surface coating in composition with
nanomagnetic particles, received from their spectra, was
recorded by FTIR spectrometer (Tensor27, Bruker Cor.,
Germany) over a range between 400 and 4,000 cm−1, at
room temperature (26°C ± 1°C). Moreover, structural
characterization of the SPGO was collected on an X-ray
diffractometer (XRD, PW1800, Philips). After filtration
and dialysis, the nanoparticle concentrations were deter-
mined by induced coupled plasma-atomic emission
spectroscopy (Varian-Liberty 150 AX Turbo, USA). In
addition, magnetic strength measurements of SPGO and
Gd2O3-DEG were executed with commercial vibrating
sample magnetometer (VSM, 7400 model, Lakeshore
Cryotronics Inc, OH, USA).
Relaxivity measurements
The signal intensity (SI) and longitudinal (T1) and trans-
verse (T2) relaxation times were measured by 1.5 T MRI
scanner (Siemens AG, Germany) using the head coil.
After both types of dialyses (1,000 and 12,000 Da),nanomagnetic concentration measurements done by
ICP, then T1 and T2 changes in aqueous solution for
Gd-DTPA, and three synthesized nanomagnetic particles
of Gd2O3-DEG, SPGO-mPEG-silane550 and 2000 were
accomplished by diluting them in 5 ml water with Gd
concentration at a range of 0.1, 0.3, 0.6, 0.9, 1.2, 1.5, 2,
and 2.5 mM (mmol/L). T1 relaxation time for each sample
was obtained by varying repetition times (TR = 100, 200,
400, 600, 2,000 ms) with fixed echo time at TE = 15 ms.
Similarly, T2 relaxation times were measured by vary-
ing echo times (TE = 30, 60, 90, 120 ms) and fixed
TR = 3,000 ms, and imaging parameters of slice thickness
of 5 mm, 1 mm gap, 512 × 384 matrix size, and 25 cm2
field of view. Signal intensities were obtained with manu-
ally drawn regions of interest for each sample. Relaxation
rates of R1 (1/T1) and R2 (1/T2) were calculated by
exponential curve fitting of the signal intensity vs. time
(TR or TE) according to Equation 1. After relaxation rate
determination for different concentrations, the R1 or R2 vs.
concentration curve were plotted and, thereby, the
relaxivities (r1 and r2) as the slope of Equation 2 could
be calculated.
Results
Characterization of the contrast materials
Table 1 shows the size and polydispersity index (PdI)
measurements using DLS; thereby, Gd2O3-DEG nano-
particles had a hydrodynamic diameter distribution of
5.9 ± 0.13 nm with a PdI of 0.390, while SPGO-mPEG-
silane550 and 2000 were 51.3 ± 1.46 nm and 194.2 ±
22.1 nm with PdI of 0.350 and 0.225, respectively. The
results showed that when molecular weight increases,
the nanoparticle size increase as well. However, despite
their different sizes, PdIs of nanoparticles (as an index of
the nanoparticle dispersion) had acceptable ranges of
less than 0.5.
Figure 1 shows the morphology of three wrapped
around nanoparticles, while specifically, just images of
Gd2O3-DEG are sharp and uniform such that spherical
or ellipsoidal shape of Gd nanomagnetic particles could
be visualized separately with clear grains in nano dimen-
sions. The images of two other PEGylated nanoparticles,
because of large molecular weights, were agglomerated
such that they could not been viewed as sharp as
Gd2O3-DEG nanoparticles among their surface covers.
Figure 1 TEM images of nanoparticles. TEM images for (a) Gd2O3-DEG, (b) SPGO-mPEG-silane550, (c) SPGO-mPEG-silane2000. Uniformity and
spherical or ellipsoidal shape for Gd2O3-DEG and agglomeration for two other nanoparticles are observed.
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bands of different ligands after coating Gd2O3nanoparti-
cles. Figure 2 shows a comparison of the FTIR spectrum
of pure diethyleneglycol with the DEG-coated Gd2O3
nanocrystals prepared by the polyol method. The bands
in DEG at 2,876 and 1,460 cm−1 correspond to the
symmetric stretching and bending of CH2 (Figure 2b).
A band at 1,127 cm−1 corresponds to C-O stretch, and the
broad band of O-H stretch was observed in the 3,100 toFigure 2 FTIR spectra for DEG coatings nanoparticles. FTIR
spectra of (a) commercial Gd2O3 powder (b) pure DEG. (c) Gd2O3
nanocrystals prepared by DEG coating without dialysis and
centrifuge. (d) Gd2O3 nanocrystals prepared by DEG coating after
dialysis and centrifuge. Curves (c) and (d) show effects of new
synthesis route in chemical composition.3,500 cm−1 range. There are no significant differences
between FTIR spectra in Figure 2d, c due to the presence
of extra DEG molecules; after the coated Gd2O3 was
cleaned up by dialysis and centrifuge, unreacted DEG has
been removed. After coating Gd2O3 with DEG, shifts in
the bands of DEG can be observed in the Gd2O3-DEG
surface. It seems that shifts in the position of CH2 and
C-O stretching of DEG are due to bonding to Gd2O3
molecules. Furthermore, the peak shifts from 1,127 to
1,120 cm−1 suggest a new configuration for DEG mole-
cules, which oxygen bind to the two Gd atoms and had
also been observed by Pedersen et al. [22].
FTIR spectrum for mPEG-silane550 is compared with
that of the SPGO-mPEG-silane550 in Figure 3a, d, re-
spectively. The FTIR spectrum of the mPEG-silane550
(Figure 3a) displays a peak at 1,284 cm−1 corresponding
to Si-C stretching vibration. The bands at 2,876 and
1,458 cm−1 correspond to the symmetric stretching and
bending of CH2. The bands at 1,627, 1,107, and 3,100
to 3,500 cm−1 correspond to C=O stretching vibration,
C-O ether, and N-H stretching vibration, respectively.
The band at 1,551 cm−1 corresponds to -NH bending
vibration in the amide link between the silane and the
PEG. The shifts of the characteristic peaks of the mPEG-
silane550 to 1,247.21 and 2,925 cm−1 (Figure 3d) are
strong evidences that PEG bonded to the surface of
Gd2O3 through a reaction of mPEG-silane550 with the
nanoparticles surface also been observed by Wu et al.
[23]. The bands at 850 and 1,500 cm−1 are common be-
tween mPEG-silane550 and SPGO-PEG-silane550 after
coating SPGO with mPEG-silane550. The spectrum of
SPGO-PEG silane2000 is very similar with that of
SPGO-PEG silane550, and they have very little differ-
ences most likely due to size effects or molecular weight
(Figure 3b, e).
The structural properties of SPGO in Figure 4 showed
XRD electron diffraction patterns of nanoparticles that
compared with reference code 00-012-0797 of CSD-
Profan database in 25°C, included are diffraction angles
and intensities that are consistent with standard refer-
ence pattern.
Figure 3 FTIR spectra for DEG PEGylated nanoparticles. FTIR
spectra of (a) mPEG-silane550 powder, (b) mPEG-silane2000 powder,
(c) a commercial SPGO powder, (d) mPEG-silane550-coated Gd2O3
nanoparticles, and (e) mPEG-silane2000-coated Gd2O3 nanoparticles.
Figure 5 Magnetometry graphs for SPGO and Gd2O3-DEG.
Graphs of (a) SPGO and (b) Gd2O3-DEG magnetization (emu/g)
plotted as a function of applied field (Oe). VSM magnetometry
shows paramagnetic behavior of SPGO. Also, magnetization curve
with S shape (sigmoidal) of Gd2O3-DEG nanoparticle is shown in (b)
is similar to superparamagnetic materials.
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DEG nanoparticles were measured by VSM at room
temperature. The relative magnetization curves vs. ap-
plied field were plotted in Figure 5. For paramagnetic,
diamagnetic, and superparamagnetic materials, when the
applied magnetic field is removed, they should exhibit no
coercivity and remanence. Also, paramagnetic materials
have a linear relationship between magnetization (M) andFigure 4 XRD pattern for SPGO. Intensities and diffraction angles were a
(ref. code: 00-012-0797).applied field (H) with positive slope. As shown in
Figure 5a, SPGO particles revealed paramagnetic proper-
ties. Also, magnetization curve with S shape (sigmoidal) of
Gd2O3-DEG nanoparticle is shown in Figure 5b, which is
similar to superparamagnetic materials. Thereby, the dif-
ference between SPGO and Gd2O3-DEG in relation to
covering Gd2O3 with DEG could be seen clearly in
Figure 5b.ccording with the standard reference pattern: CSD-Profan database
Table 2 Results of relaxometry for three nanoparticle
contrast agents and Gd-DTPA
Nanoparticle r2/r1 r2 (mM
−1 s−1) r1 (mM
−1 s−1)
Gd-DTPA 1.13 5.14 4.55
Gd2O3-DEG 0.89 11.81 13.31
SPGO-mPEG-silane550 33.34 26.34 0.79
SPGO-mPEG-silane2000 33.72 33.72 1.00
Longitudinal relaxivity (r1) of Gd-DTPA PEGylated nanoparticles (SPGO-mPEG-
silane550 and 2000) was smaller than that of Gd2O3-DEG.
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Nanoparticle tubes were prepared by certain concentra-
tions (Figure 6). Ri (1/Ti, i = 1, 2) vs. Gd concentration
curve were plotted, and the slope of the curve or relaxiv-
ity (ri) was obtained for each nanoparticle (Table 2). Gd
concentration shows a linear relationship up to 1.5 mM
with a good of fit r > 0.98 according to Equation2
(Figure 7).
Figure 7a shows the longitudinal relaxation rates (1/T1)
for the used materials. Gd2O3-DEG had longitudinal pro-
ton relaxivity at least 2.5 times higher than Gd-DTPA,
whereas r1 for SPGO-mPEG-silane550and 2000 was less
compared with Gd-DTPA. That is why, unlike Gd2O3-
DEG and Gd–DTPA, R1 relaxation rates of SPGO-
mPEG-silane550 and 2000 did not change considerably
with concentration. In Figure 8b, for all of nanoparticleFigure 6 Arrangement of nanoparticle tubes for imaging and
relaxometry. Signal intensities for Gd2O3-DEG were more than
Gd-DTPA and two other nanoparticles. The quantitative variation
results of signal intensities in Figure 8b are in complete accordance
with the image visualization in relation to in vitro dilutions of the
three materials. Signal intensities displayed a relatively steep increase
when approaching a more gradual increase, thereafter.materials and Gd-DTPA, the change of Gd concentration
led to the increase of transverse relaxation rates (1/T2),
while this effect is significantly higher for SPGO-mPEG-
silane550 and 2000 compared to Gd2O3-DEG and
Gd–DTPA (Figure 7b, Table 2).
Determination of maximum signal intensities for different
concentrations
Figure 8 shows the signal intensity curves for Gd-DTPA,
Gd2O3-DEG, SPGO-mPEG-silane550, and SPGO-mPEG-
silane2000 using TR/TE = 600/15 ms. The maximum
signal intensities for Gd2O3-DEG, SPGO-mPEG-silane550,
and SPGO–mPEG-silane2000 were found in 0.6, 0.6,
and 0.9-mM concentrations, respectively.
Discussion
Contrast agents can modify the signal intensity in differ-
ent tissues to enhance their contrast and improve the
low sensitivity of magnetic resonance imaging. The effi-
ciency of the contrast agents according to different ab-
sorption of agents is determined by ri that changes the
longitudinal and transverse relaxation times to result dif-
ferences among adjacent tissues. These changes are cate-
gorized according to the signal intensity produced on T1
and T2-weighted images: ‘positive’ known as high signal
intensity or ‘negative’ as low signal intensity. Recently,
studies have shown high efficiency and sensitivity of
contrast agents when they have been used in nanoparti-
cle forms. To have higher relaxivity, reduce toxicity, in-
crease biocompatibility and half-life, besides preventing
the nanoparticle aggregations, contrast agents in MRI
should be coated with various materials. Different factors
could affect the sizes of nanoparticles including type of
the core, coating molecular weights, nanoparticle aggre-
gation and, thereby, the synthesis route. Theoretically,
by increasing molecular weights of nanoparticle coat-
ings, their average size could be increased as well [24].
For this reason, in this study, we investigated magnetic
properties of three Gd-based nanoparticles with different
coatings of DEG, mPEG-silane550, and mPEG-
silane2000 comparing to conventionally extracellular
Gd-DTPA contrast agent. For nanoparticle synthesis,
two different methods were used. Firstly, the preparation
and coating of Gd2O3 by previous polyol route besides
Figure 7 Longitudinal (R1) (a) and transversal (R2) (b) relaxation rates vs. concentration. The slope of the curve or relaxivity (r1 and r2) was
obtained for Gd-DTPA (diamond), Gd2O3-DEG (square), SPGO-mPEG-silane550 (triangle), and SPGO-mPEG-silane2000 (cross). The solid lines
represent the linear regression of the data. Gd2O3-DEG had longitudinal proton relaxivity at least 2.5 times higher than Gd-DTPA, whereas r1 for
SPGO-mPEG-silane550 and 2000 was less compared with Gd-DTPA.
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membranes led to reach the good and desirable smaller
size of approximately 5 nm of gadolinium crystal nano-
particles covered by DEG in Gd2O3-DEG compounds.
Secondly, for mPEG-silane550 and mPEG-silane2000,
despite using filtration and sonication after PEG coating
method for elimination aggregated particles prior to
DLS measurement, PEGylated nanoparticles even still
had relatively larger sizes of approximately 51.3 and ap-
proximately 194.2 nm. For this, part of that increase size
should be due to the effect of their molecular weights.
In our study, molecular weights of three materials were
as follows: MWSPGO-mPEG-silane2000 > MWSPGO-
mPEG-silane550 > MW Gd2O3-DEG. As seen in Table 1,
the measured particle sizes have an incremental behavior
as the molecular weight has increased, which are in ac-
cordance with their appearance in related TEM images.
Magnetic properties in MRI were related to relaxivities
(r), especially, r2/r1 ratio that defines the potential for
being a positive or negative contrast agent. Meanwhile,
several studies have investigated the size effects on mag-
netic properties and relaxivities, e.g., SPIO nanoparticles
with hydrodynamic diameters of 9, 12, and 15 nm had
r2/r1 ratio of 2.75, 5.95, and 13.08, respectively [22,23].Some other studies have also showed that the r2/r1 ratio
increases with larger sizes of nanoparticles [14,25,26].
Consequently, in this study, the changes of coating
materials with various molecular weights on a similar
core were also studied in terms of r2/r1 ratios which
have been shown in Table 2. Thereby, it is clear that
those r2/r1 ratios for Gd2O3-DEG were much lower than
that of other two PEGylated materials. Meanwhile, even
for SPGO-mPEG-silane2000, the said ratio was a bit
higher than SPGO-mPEG-silane550.
For positive contrast agents, r2/r1 ratio is described to
be 1 to 2 and for negative ones; however, it is between 2
and 40 [21]. Thus, in our study, Gd2O3-DEG (with r2/r1
ratio = 0.89) could reveal good results as a positive
contrast agents even better than Gd-DTPA (with r2/r1
ratio = 1.13) [10-12], that is in part because of such
small size nanoparticles that could be yielded in the new
synthetic method in this research. However, r2/r1 ratios
for PEGylated nanoparticles are relatively high. In one
study, PEGylated SPGO with higher MW (MW = 6,000
Da) resulted to an r2/r1 ratio equal to 81.6 [20]. In this
study, we used polymers with a lower molecular weight
(i.e., 550 and 2,000) and so the r2/r1 ratios could be
reached to 33.34 and 33.72, respectively. These
Figure 8 Signal intensities for contrast agents. Relative signal intensities in (a) Gd-DTPA and Gd2O3-DEG. (b) SPGO-mPEG-silane550 and
SPGO-mPEG-silane2000 (TR = 600 ms and TE = 15 ms). Maximum signal intensity for Gd2O3-DEG was obtained (0.6 mM), whereas it was 1.5 mM
for Gd-DTPA.
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the selected lower molecular weight materials. Further-
more, the relaxivity results in Figure 7a, b indicate that
Gd2O3-DEG nanoparticles (with lower r2/r1 ratio) as
positive contrast agents are clearly more appropriate
than Gd-DTPA. SPGO-mPEG-silane550 and 2000 due
to having both high r2 and high r2/r1 ratio appear to be
proper contrast agents for T2-weighted MR imaging
methods, as well.
According to Equations 1 and 2, signal intensities
change with T1, T2, and the concentration of contrast
agents. Therefore, short T1 leads to a signal increase,
whereas, short T2 decreases the signal. A maximum sig-
nal occurs at intermediate concentrations; such expecta-
tions could be seen clearly in Figure 8a, b. In addition,
the maximum signal intensity for Gd2O3-DEG occurred
at similar daily clinical concentration relative to Gd-DTPA with similar intensity (0.6 mM near to 0.1 mM;
Figure 8a). Also, signal intensities for SPGO-mPEG-
silane550 and SPGO-mPEG-silane2000 were much less
than the two other contrast agents (Figure 8b). This is
another conformation that they can be considered as
negative or T2-wieghted contrast agents. This could be
remained for future experiment for them to be com-
pared with other negative contrast agents such as iron
oxide-based ones.
Conclusions
The synthesis controlled method making use of dialysis,
filtration, and sonication could have direct effect on the
nanosize scale and magnetic characterization of nano-
particles, consequently on their r2/r1 ratio as providing
and giving them a positive or negative signal properties of
contrast agents. Thereby, in our study, the Gd2O3-DEG
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synthesized Gd2O3-DEG could be achieved. Moreover,
for preparation of PEGylated contrast agents, polymers
with lower molecular weights could potentially have better
contrast properties as behaving like negative contrast
agents that should be compared with other similar
negative ones.
Therefore, among different group coating materials,
DEG and PEG, due to their considerable properties and
not having fixed sizes (different molecular weights), were
selected as useful surface covering of nanomagnetic par-
ticles that could reveal noticeable relaxivity, magnetic
property, and signal intensity that are proper for cellular
and molecular MRI applications that would be remained
for future in vivo studies.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GA and NRA designed the study, carried out all of the experimental work
and data acquisitions, and drafted the manuscript. SH and EG performed the
synthesis and the interpretation of nanoparticles' chemical structure. HRM
contributed in drug regulations consultancy. RZ participated in material
characterizations. BR carried out the magnetic resonance imaging protocols.
All authors read and approved the final manuscript.
Authors' information
NRA was born in 1960 in Shiraz, Iran, received his BSc in Nuclear Physics
from Shiraz University, Shiraz, Iran, in 1986, his MSc and Ph.D. in Medical
Physics (Medical Imaging) from Nagoya University, Nagoya, Japan in 1995. At
present, he is a professor in the Medical Physics at the Department of
Medical Physics & Biomedical Engineering, School of Medicine, Tehran
University of Medical Sciences (TUMS). His research interests during Ph.D.
graduation was in computer-aided diagnostic (CAD) systems for the
detection of cancer on digital mammograms, leading to development of
software algorithms and CAD systems for mammographic cancer detection.
As a PIP member of the American Association in Medical Physics (AAPM)
and other scientific forums, he published many articles and several books in
Medical Imaging aspects, achieved awards in innovation, scientific
hypothesis and inventions, and paper awards in world conferences. Recently,
his research interests have been focusing on the development of
nanomagnetic particles for MRI applications. The development of the
present work in combination with the magnetoliposomes as tumor cell
tracking and drug delivery system for liver specific target detection has been
accepted and will be presented in RSNA2012.
SH was born in 1960 in Abadan, Iran, and received her BSc and MSc in
Analytical Chemistry from Shiraz University, Shiraz, Iran, in 1990, and her Ph.
D. in Pharmaceutics from Nagoya University in Japan in 1995. Her Ph.D.
research was related to pharmacokinetics of drugs, especially drug
characterization in brain distribution. At present, she is an associate professor
in the Pharmaceutical Department, Food & Drug Laboratory Research Center,
Food & Drug Organization (FDO), Ministry of Health, Tehran, Iran. She is the
head of QC approving of herbal medicine and supplements in Iran FDO and
also has been the lecturer of GLP and GMP at the universities while
performing many workshops for drug factories. Her recent research interest
is in the synthesis and analytical method development of nanosized
molecules for drug delivery applications.
HRM received his Pharm D from Tabriz University and his Ph.D. in
Pharmaceutics from the University of Bradford, England in 1995. He has been
a member of the Fellowship in Liposomal Gene Delivery in Cancer,
University of Alberta, Canada. At present, he is a professor of Pharmaceutics
in School of Pharmacy, Shahid Beheshti University of Medical Sciences,
Tehran, Iran. His research interests have been related to transdermal drug
delivery, modeling biological barriers, gene delivery, liposomal drug delivery,
and lyotropic liquid crystals. He has been also the Director General of some
drug factories.GA is a Ph.D. candidate who received his BSc in Physics from Bu Ali Sina
University in 1991, his MSc in Medical Physics from Tehran University of
Medical Sciences (TUMS) and now is going to graduate in Medical Physics
from Tehran University. He has been the employee and the lecturer of
Medical & Radiation Physics in School of Medicine of Hamadan University of
Medical Sciences since 2000. His research interests during his MSc has been
related to medical imaging and now during his PhD graduation he has been
involving with the development of magnetic nanoparticle sizes for MRI
applications.
RZ, a Ph.D. candidate, received his BSc in Physics from Tehran University of
Medical Sciences in1999, his MSc in Medical Physics from Tabriz University of
Medical Sciences and now is going to graduate in Medical Physics from
Tehran University. His research interest is related to magnetoliposome
nanosize particles application for MRI applications.
EG received her BSc in Chemistry from the Islamic Azad University of Tehran
University and her MSc from the University of Zanjan (ZNU). She is a
research fellow in Food & Drug Laboratory Research Center, Food & Drug
Organization (FDO), Ministry of Health, Tehran, Iran. Her research interests in
MSc has been in the preparation of gold nanoparticles coated by amino
acids and the study of the kinetically influence tubulin protein in vitro, and at
present, is working on the synthesis development for contrast agent
nanosize particles for MRI applications.
BR received his BSc in Radiology from Iran Medical University in 1990 and his
MSc in Medical Physics from Iran Medical University in 2001. At present, he is
an employee of Medical Imaging Center in Emam Hospital Complex, School
of Medicine. He has been contributing to so many researches with different
departments and researchers; he is qualified in developing different MRI
imaging protocols. At present he is responsible for performing new and
proper MRI data acquisitions in nanomagnetic contrast agents and MRI
neuroimaging applications.
Acknowledgments
This paper is supported by the Chancellor Research of Tehran University of
Medical Sciences (TUMS).
Author details
1Medical Physics & Biomedical Engineering Department, School of Medicine,
Tehran University of Medical Sciences (TUMS), Keshavaz blvd, 16 Azar St.,
Tehran 14145, Iran. 2Pharmaceutical Department, Food & Drug Laboratory
Research Center, Food & Drug Organization (FDO), Ministry of Health, Imam
St., Valiasre Cross, Tehran 1113615911, Iran. 3Medical Imaging Center, Imam
Hospital Complex, School of Medicine, Tehran University of Medical Sciences
(TUMS), Keshavaz Blvd., Tehran 1419733141, Iran. 4Department of
Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical
Sciences, Valiasre Ave., Niayesh Junction, Tehran 141556153, Iran.
Received: 10 April 2012 Accepted: 22 September 2012
Published: 3 October 2012
References
1. Pereira GA, Geraldes CFGC: Design and optimization of gadolinium based
contrast agents for magnetic resonance imaging. Ann Magn Reson 2007,
6(1):1–33.
2. Hengerer A, Grimm J: Molecular magnetic resonance imaging. Biomed
Imaging Interv J 2006, 2(2):1–7.
3. Kuriashkin IV, Losonsky JM: Contrast enhancement in magnetic resonance
imaging using intravenous paramagnetic contrast media: a review. Vet
Radiol Ultrasound 2000, 41(1):4–7.
4. Gould P: Nanomagnetism shows in vivo potential. Nano Today 2006,
1(4):34–39.
5. Laurent S, Elst LV, Muller RN: Comparative study of the physicochemical
properties of six clinical low molecular weight gadolinium contrast
agents. Contrast Med Mol Imaging 2006, 1(3):128–137.
6. Frame EM, Uzgiris EE: Gadolinium determination in tissue samples by
inductively coupled plasma mass spectrometry and inductively coupled
plasma atomic emission spectrometry in evaluation of the action of
magnetic resonance imaging contrast agents. Analyst 1998,
123(4):675–679.
7. McDonald MA, Watkin KL: Investigations into the physicochemical
properties of dextran small particulate gadolinium oxide nanoparticles.
Acad Radiol 2006, 13(4):421–427.
Azizian et al. Nanoscale Research Letters 2012, 7:549 Page 10 of 10
http://www.nanoscalereslett.com/content/7/1/5498. Waters EA, Wickline SA: Contrast agents for MRI. Basic Res Cardiol 2008,
103(2):114–121.
9. Pankhurst QA, Connolly J, Jones SK, Dobson J: Applications of magnetic
nanoparticles in biomedicine. J Phys D: Appl Phys 2003, 36:167–181.
10. Söderlind F, Pedersen H, Petrol RM Jr, Käll PO, Uvdal K: Synthesis and
characterization of Gd2O3nanocrystals functionalized by organic acids.
J Colloid Interface Sci 2005, 228(1):140–148.
11. Engström M, Klasson A, Pedersen H, Vahlberg C, Käll PO, Uvdal K: High
proton relaxivity for gadolinium oxide nanoparticles. MAGMA 2006,
19(4):180–186.
12. Klasson A, Ahrén M, Hellqvist E, Söderlind F, Rosén A, Käll PO, Uvdal K,
Engström M: Positive MRI enhancement in THP-1 cells with Gd2O3
nanoparticles. Contrast Media Mol Imaging 2008, 3(3):106–111.
13. Riyahi-Alam N, Behrouzkia Z, Seifalian A, Haghgoo Jahromi S: Properties
evaluation of a new MRI contrast agent based on Gd-loaded
nanoparticles. Biol Trace Elem Res 2010, 137(3):324–334.
14. Faucher L, Gossuin Y, Hocq A, Fortin MA: Impact of agglomeration on the
relaxometric properties of gadolinium oxide nanoparticles.
Nanotechnology 2011, 22(29):295103.
15. Kamaly N, Pugh JA, Kalber TL, Bunch J, Miller AD, McLeod CW, Bell JD:
Imaging of gadolinium spatial distribution in tumor tissue by laser
ablation inductively coupled plasma mass spectrometry. Mol Imaging
Biol 2010, 12(4):361–366.
16. Doiron AL, Chu K, Ali A, Brannon-Peppas L: Preparation and initial
characterization of biodegradable particles containing gadolinium-DTPA
contrast agent for enhanced MRI. Proc Natl Acad Sci U S A 2008,
105(45):17232–17237.
17. Schipper ML, Iyer G, Koh AL, Cheng Z, Ebenstein Y, Aharoni A, Keren S,
Bentolila LA, Li J, Rao J, Chen X, Banin U, Wu AM, Sinclair R, Weiss S,
Gambhir SS: Particle size, surface coating, and PEGylation influence the
biodistribution of quantum dots in living mice. Small 2009, 5(1):126–134.
18. Mulder WJ, Strijkers GJ, Briley-Saboe KC, Frias JC, Aguinaldo JG, Vucic E,
Amirbekian V, Tang C, Chin PT, Nicolay K, Fayad ZA: Molecular imaging of
macrophages in atherosclerotic plaques using bimodal PEG-micelles.
Magn Reson Med 2007, 58(6):1164–1170.
19. Oyewumia MO, Yokel RA, Jay M, Coakley T, Mumper RJ: Comparison of cell
uptake, biodistribution and tumor retention of folate-coated and
PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control
Release 2004, 95(3):613–626.
20. Nelson J, Bennett LH, Wagner MJ: Solution synthesis of gadolinium
nanoparticles. J Am Chem Soc 2002, 124(12):2979–2983.
21. Fortin MA, Petoral RM, Söderlind F, Klasson A, Engström M, Veres T, Käll PO,
Uvdal K: Polyethylene glycol-covered ultra-small Gd2O3 nanoparticles for
positive contrast at 1.5 T magnetic resonance clinical scanning.
Nanotechnology 2007, 18(39):395501–395510.
22. Pedersen H, Söderlind F, Petrol RM Jr, Uvdal K, Käll PO, Ojamäe L: Surface
interactions between Y2O3 nanocrystals and organic molecules - an
experimental and quantum-chemical study. Surface Sci 2005,
592(1–3):124–140.
23. Wu Y, Zuo F, Zheng Z, Ding X, Peng Y: A novel approach to molecular
recognition surface of magnetic nanoparticles based on host–guest
effect. Nanoscale Res Lett 2009, 4(7):738–747.
24. Casula MF, Corrias A, Arosio P, Lascialfari A, Sen T, Floris P, Bruce IJ: Design
of water-based ferrofluids as contrast agents for magnetic resonance
imaging. J Colloid Interface Sci 2011, 357(1):50–55.
25. Casula MF, Floris P, Innocenti C, Lascialfari A, Marinone M, Corti M, Sperling
R, Parak WJ, Sangregorio C: Magnetic resonance imaging contrast agents
based on iron oxide superparamagnetic ferrofluids. Chem Mater
2010, 22:1739–1748.
26. Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, Zhou J, Zhu J, Gao X:
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation
and biodistribution in rats. J Control Release 2001, 71(2):203–211.
doi:10.1186/1556-276X-7-549
Cite this article as: Azizian et al.: Synthesis route and three different
core-shell impacts on magnetic characterization of gadolinium oxide-
based nanoparticles as new contrast agents for molecular magnetic
resonance imaging. Nanoscale Research Letters 2012 7:549.Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
